Allergy Diagnostic Test Based on Microchip Technology
Not Applicable
Not yet recruiting
- Conditions
- AllergyAllergy DrugAllergy;FoodAllergy Pollen
- Interventions
- Diagnostic Test: Newly developed microarray-based diagnostic test systemDiagnostic Test: Routine allergy tests
- First Posted Date
- 2023-12-12
- Last Posted Date
- 2023-12-12
- Target Recruit Count
- 400
- Registration Number
- NCT06167564
- Locations
- 🇧🇾
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus
Assesment of the Functional Activity of Platelets for the Differential Diagnosis of Thrombocytopathies
Not yet recruiting
- Conditions
- ThrombocytopathyHemorrhagic DisordersImmune ThrombocytopeniaAcute Leukemia
- Interventions
- Diagnostic Test: Flow cytometryDiagnostic Test: Platelet aggregation and plasma coagulation
- First Posted Date
- 2022-12-16
- Last Posted Date
- 2022-12-16
- Target Recruit Count
- 200
- Registration Number
- NCT05654766
Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells
Phase 2
- Conditions
- Tracheal StenosisLaryngeal Stenosis
- Interventions
- Biological: Olfactory mucosa-derived mesenchymal stem cellsOther: Patients treated according to current clinical protocols
- First Posted Date
- 2022-09-10
- Last Posted Date
- 2022-09-10
- Target Recruit Count
- 20
- Registration Number
- NCT05535803
- Locations
- 🇧🇾
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus
Treatment of Patients With Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles
Phase 1
- Conditions
- Segmental Fracture - Bone Loss
- Interventions
- Other: Standard treatment of bone defectsBiological: Mesenchymal stem cells enriched by extracellular vesicles
- First Posted Date
- 2022-08-29
- Last Posted Date
- 2022-08-29
- Target Recruit Count
- 20
- Registration Number
- NCT05520125
- Locations
- 🇧🇾
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus
Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells
Phase 1
- Conditions
- Recurrent Pregnancy Loss
- Interventions
- Biological: Mesenchymal stem cells capable of differentiation in the endometrial-decidual directionOther: Standard treatment according to the clinical protocols
- First Posted Date
- 2022-08-29
- Last Posted Date
- 2022-08-29
- Target Recruit Count
- 20
- Registration Number
- NCT05520112
- Locations
- 🇧🇾
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus
Treatment of Systemic Sclerosis With Autologous Regulatory Т-cells
Phase 1
- Conditions
- Systemic Sclerosis
- Interventions
- Other: Standard treatment according to the clinical protocolsBiological: Autologous Regulatory Т-cells
- First Posted Date
- 2022-01-28
- Last Posted Date
- 2022-09-14
- Target Recruit Count
- 30
- Registration Number
- NCT05214014
- Locations
- 🇧🇾
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus
Treatment of Alopecia Using Follicular Stem Cells
Phase 1
- Conditions
- Alopecia
- Interventions
- Biological: Follicular stem cellsOther: Standard treatment according to the clinical protocols
- First Posted Date
- 2022-01-27
- Last Posted Date
- 2022-01-27
- Target Recruit Count
- 30
- Registration Number
- NCT05210452
The Treatment of Patients With Type 1 Diabetes Mellitus With Autologous Tolerogenic Dendritic Cells
Phase 1
- Conditions
- Diabetes Mellitus
- Interventions
- Biological: Autologous tolerogenic dendritic cellsOther: Standard treatment according to the clinical protocols
- First Posted Date
- 2022-01-26
- Last Posted Date
- 2022-01-26
- Target Recruit Count
- 30
- Registration Number
- NCT05207995
Treatment of Postoperative Hypoparathyroidism Using Cultured Allogenic Parathyroid Cells
Phase 1
- Conditions
- Postoperative Hypoparathyroidism
- Interventions
- Biological: Allogenic parathyroid cellsOther: Standard treatment according to the Clinical protocols
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2022-01-13
- Target Recruit Count
- 20
- Registration Number
- NCT05186883
Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells
Phase 1
- Conditions
- Age-Related Macular Degeneration
- Interventions
- Biological: Cultured retinal stem and progenitor cellsOther: Standard treatment according to the clinical protocols
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2022-09-14
- Target Recruit Count
- 20
- Registration Number
- NCT05187104
- Locations
- 🇧🇾
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus
© Copyright 2025. All Rights Reserved by MedPath